Sex-differences in reporting of statin-associated diabetes mellitus to the US Food and Drug Administration
Introduction Diabetes mellitus (DM) is increasingly recognized as a possible consequence of statin therapy.Secondary analysis of randomized clinical trials and limited observational cohort analyses have suggested that women may be more likely than men to experience statin-associated DM.No analyses of real-world drug safety data addressing this ques